Nakamoto, Inc. (NAKA)
5.00
-0.79
(-13.64%)
USD |
NASDAQ |
Nov 13, 16:00
4.93
-0.07
(-1.40%)
After-Hours: 19:59
Nakamoto Enterprise Value : 237.18M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 237.18M |
| November 12, 2026 | 251.68M |
| November 11, 2026 | 260.12M |
| November 10, 2026 | 253.15M |
| November 09, 2026 | 252.41M |
| November 06, 2026 | 249.48M |
| November 05, 2026 | 247.64M |
| November 04, 2026 | 255.90M |
| November 03, 2026 | 249.11M |
| November 02, 2026 | 247.09M |
| October 30, 2026 | 252.96M |
| October 29, 2026 | 271.68M |
| October 28, 2026 | 276.26M |
| October 27, 2026 | 276.81M |
| October 26, 2026 | 269.02M |
| October 23, 2026 | 280.48M |
| October 22, 2026 | 286.54M |
| October 21, 2026 | 300.39M |
| October 20, 2026 | 276.45M |
| October 19, 2026 | 278.10M |
| October 16, 2026 | 276.26M |
| October 15, 2026 | 293.88M |
| October 14, 2026 | 291.49M |
| October 13, 2026 | 302.86M |
| October 12, 2026 | 296.99M |
| Date | Value |
|---|---|
| October 09, 2026 | 302.13M |
| October 08, 2026 | 309.29M |
| October 07, 2026 | 316.81M |
| October 06, 2026 | 321.03M |
| October 05, 2026 | 329.83M |
| October 02, 2026 | 322.68M |
| October 01, 2026 | 312.59M |
| September 30, 2026 | 319.01M |
| September 29, 2026 | 320.29M |
| September 28, 2026 | 319.57M |
| September 25, 2026 | 324.40M |
| September 24, 2026 | 320.29M |
| September 23, 2026 | 310.18M |
| September 22, 2026 | 322.25M |
| September 21, 2026 | 325.48M |
| September 18, 2026 | 309.73M |
| September 17, 2026 | 297.74M |
| September 16, 2026 | 292.37M |
| September 15, 2026 | 284.85M |
| September 14, 2026 | 292.55M |
| September 11, 2026 | 292.19M |
| September 10, 2026 | 284.50M |
| September 09, 2026 | 288.43M |
| September 08, 2026 | 287.90M |
| September 04, 2026 | 291.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 1.922B |
| Agilon Health, Inc. | 1.664B |
| Starling Oncology, Inc. | 422.80M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 153.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 85.81M |
| Revenue (Quarterly) | -1.929M |
| Total Expenses (Quarterly) | -87.74M |
| EPS Diluted (Quarterly) | 4.068 |
| Profit Margin (Quarterly) | -4.45K% |
| Earnings Yield | -293.5% |
| Normalized Earnings Yield | -123.00 |